Skip to main content
NVDA-1.19%AAPL+0.67%GOOGL-2.28%MSFT-0.48%AMZN-0.82%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.20%TSLA-1.97%SKHY+7.05%MU-3.05%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.91%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%0005.HK-0.78%AP2d-2.69%UNH-1.94%DELL+0.29%HSBA.L-1.34%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.62%AUDJPY-1.87%CHFJPY-1.71%NZDCAD-1.45%GBPJPY-1.39%EURJPY-1.38%NZDUSD-1.37%EURNZD+1.28%USDJPY-1.28%GBPNZD+1.24%CADJPY-1.19%NZDCHF-0.95%USDZAR+0.95%USDSEK+0.88%USDNOK+0.87%AUDNZD+0.78%AUDCAD-0.72%EURZAR+0.67%USDTHB+0.61%USDMXN+0.61%AUDUSD-0.61%EURSEK+0.60%GBPZAR+0.59%EURNOK+0.59%AUDSGD-0.54%USDPLN+0.53%AUDDKK-0.52%CADCHF+0.51%EURAUD+0.50%CHFSEK+0.49%CHFNOK+0.48%GBPAUD+0.47%USDCHF+0.45%GBPTRY+0.41%NOKJPY-0.41%NZDSGD-0.38%GBPHKD+0.32%EURCHF+0.32%GBPCHF+0.30%EURHKD-0.30%GBPMXN-0.28%USDDKK+0.28%USDSGD+0.27%EURPLN+0.25%GBPCAD-0.22%EURCAD-0.20%SGDJPY+0.19%EURCNH-0.17%AUDCHF-0.17%USDILS+0.16%CHFSGD-0.12%GBPUSD-0.12%EURUSD-0.12%USDTRY+0.11%USDCNH+0.09%GBPSGD-0.09%USDCAD-0.08%PLNJPY-0.07%NZDMXN-0.06%AUDNOK+0.06%USDCOP-0.04%EURCZK-0.03%EURGBP+0.03%EURSGD-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.86%XAGUSD-4.32%GAGUSD-4.32%HG1-4.09%UKOIL+3.27%USOIL+3.15%COFFEE-2.45%GAUUSD-1.17%XAUUSD-1.17%SUGAR+1.15%COTTON+0.60%XNGUSD-0.29%BTCUSD-1.81%ETHUSD-2.01%USDTUSD-0.02%XRPUSD-2.77%SOLUSD-2.07%TRXUSDT-0.17%ZECUSDT-5.51%DOGEUSD-2.88%XMRUSDT-2.04%LINKUSD-1.08%XLMUSD-2.10%BCHUSDT-8.60%LTCUSD-2.09%UNIUSD-4.73%TONUSD+24.88%HBARUSDT-2.37%SUIUSD-2.75%TAOUSDT-4.55%AAVEUSD-3.25%DOTUSDT-2.63%ICPUSDT-1.30%ONDOUSDT-2.87%WLDUSDT-2.43%ATOMUSDT-3.41%ARBUSDT-1.04%JUPUSDT-3.82%INJUSDT-3.30%STXUSDT-3.80%FETUSDT-3.24%TIAUSDT-1.65%SEIUSDT-3.91%PYTHUSDT-1.17%IMXUSDT-3.06%WIFUSDT-4.40%GRTUSDT-3.82%OPUSDT-3.00%IOTAUSDT-3.80%POLUSDT-7.08%AXSUSDT-2.57%FARTCOINUSDT-3.67%EOSUSDT-1.86%DYDXUSDT-0.24%ORDIUSDT-0.69%GALAUSDT-4.78%NOTUSDT-0.68%RONINUSDT-2.64%NVDA-1.19%AAPL+0.67%GOOGL-2.28%MSFT-0.48%AMZN-0.82%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.20%TSLA-1.97%SKHY+7.05%MU-3.05%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.91%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%0005.HK-0.78%AP2d-2.69%UNH-1.94%DELL+0.29%HSBA.L-1.34%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.62%AUDJPY-1.87%CHFJPY-1.71%NZDCAD-1.45%GBPJPY-1.39%EURJPY-1.38%NZDUSD-1.37%EURNZD+1.28%USDJPY-1.28%GBPNZD+1.24%CADJPY-1.19%NZDCHF-0.95%USDZAR+0.95%USDSEK+0.88%USDNOK+0.87%AUDNZD+0.78%AUDCAD-0.72%EURZAR+0.67%USDTHB+0.61%USDMXN+0.61%AUDUSD-0.61%EURSEK+0.60%GBPZAR+0.59%EURNOK+0.59%AUDSGD-0.54%USDPLN+0.53%AUDDKK-0.52%CADCHF+0.51%EURAUD+0.50%CHFSEK+0.49%CHFNOK+0.48%GBPAUD+0.47%USDCHF+0.45%GBPTRY+0.41%NOKJPY-0.41%NZDSGD-0.38%GBPHKD+0.32%EURCHF+0.32%GBPCHF+0.30%EURHKD-0.30%GBPMXN-0.28%USDDKK+0.28%USDSGD+0.27%EURPLN+0.25%GBPCAD-0.22%EURCAD-0.20%SGDJPY+0.19%EURCNH-0.17%AUDCHF-0.17%USDILS+0.16%CHFSGD-0.12%GBPUSD-0.12%EURUSD-0.12%USDTRY+0.11%USDCNH+0.09%GBPSGD-0.09%USDCAD-0.08%PLNJPY-0.07%NZDMXN-0.06%AUDNOK+0.06%USDCOP-0.04%EURCZK-0.03%EURGBP+0.03%EURSGD-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.86%XAGUSD-4.32%GAGUSD-4.32%HG1-4.09%UKOIL+3.27%USOIL+3.15%COFFEE-2.45%GAUUSD-1.17%XAUUSD-1.17%SUGAR+1.15%COTTON+0.60%XNGUSD-0.29%BTCUSD-1.81%ETHUSD-2.01%USDTUSD-0.02%XRPUSD-2.77%SOLUSD-2.07%TRXUSDT-0.17%ZECUSDT-5.51%DOGEUSD-2.88%XMRUSDT-2.04%LINKUSD-1.08%XLMUSD-2.10%BCHUSDT-8.60%LTCUSD-2.09%UNIUSD-4.73%TONUSD+24.88%HBARUSDT-2.37%SUIUSD-2.75%TAOUSDT-4.55%AAVEUSD-3.25%DOTUSDT-2.63%ICPUSDT-1.30%ONDOUSDT-2.87%WLDUSDT-2.43%ATOMUSDT-3.41%ARBUSDT-1.04%JUPUSDT-3.82%INJUSDT-3.30%STXUSDT-3.80%FETUSDT-3.24%TIAUSDT-1.65%SEIUSDT-3.91%PYTHUSDT-1.17%IMXUSDT-3.06%WIFUSDT-4.40%GRTUSDT-3.82%OPUSDT-3.00%IOTAUSDT-3.80%POLUSDT-7.08%AXSUSDT-2.57%FARTCOINUSDT-3.67%EOSUSDT-1.86%DYDXUSDT-0.24%ORDIUSDT-0.69%GALAUSDT-4.78%NOTUSDT-0.68%RONINUSDT-2.64%
AP

Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ • Healthcare

$23.04
+$0.1 (+0.5%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$22.84
Previous Close$23.04
Day Range$22.57 - $23.07
Avg. Volume (3M)391.7K
Market Cap$1B
P/E Ratio13.2
52 Week Range
$16.65$29.52
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$183.9M100%
Gross Profitminus cost of goods$93.4M51%
Operating Incomeminus R&D and overhead$39.7M22%
Net Incomeminus taxes and the rest$30.3M17%

In plain terms: out of every $100 in revenue, Amphastar Pharmaceuticals, Inc. keeps $17 as net profit.

Fundamentals & Financials

Revenue (TTM)
$730M
Net Income (TTM)
$78.5M
EPS (TTM)
$1.74
ROA (TTM)
4.5%
Current Ratio
2.4
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-19.2%Q1 2026$0.73
-40.0%Q2 2026$0.42
+46.8%Q3 2026$0.91
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +46.8%

Amphastar Pharmaceuticals beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 6, 2026, with adjusted EPS of $0.91 topping the $0.62 estimate (+46.8%) and revenue of $183.9 million topping the $179.9 million estimate (+2.2%). Revenue rose 5.4% to about $183.9 million (up from $174.4 million a year ago), with sales concentrated in the United States, where revenue increased 3.2% to roughly $172.3 million, while China rose 1425.1% to about $4.6 million. Profitability came through at a gross margin of 50.8% and an operating margin of 21.6%, with operating income of roughly $39.7 million and net income edging down 2.2% to about $30.3 million (from $31.0 million a year ago). Operating cash flow was about $51.3 million, and the company repurchased roughly $45.2 million of stock during the quarter. For the next period, consensus calls for EPS of $0.86 on revenue of $197.9 million.

View full earnings history

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. develops, makes, commercializes, and distributes generic and proprietary medicines for the healthcare market, trading on the NASDAQ as AMPH. The company operates as a specialty and generic drug manufacturer with $719.9 million of revenue in FY2025, spanning finished products and insulin-based active pharmaceutical ingredients.

Name
Amphastar Pharmaceuticals, Inc.
CEO
Yongfeng Zhang
Website
www.amphastar.com
Industry
Healthcare
Year Founded
1996
Employees
1,976

Today's Snapshot

AI-generated

AMPH closed slightly higher at 23.04.

Trading Volume

Below 10d avg (409.3K)

343.4K

vs S&P 500 Today

Outperforming Market

+0.96%

Updated: September 10, 2026 at 12:13 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
AMPH is rated Strong Buy and is trading near 23.04, with a clearly bullish technical backdrop. Trend strength is pronounced according to ADX, while momentum measures including MACD and short-term moving averages register buy signals and place price above the 200-day averages. Volume-based OBV also supports accumulation, and volatility is moderate with ATR around three percent, allowing orderly moves. Oscillators like RSI are positive but not extreme, suggesting strength without overextension. The classic pivot near 22.79 does not materially contradict the bullish posture. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$21.06 - $22.79
    Buy
  • RSI (14)63.87
    Neutral
  • Stochastic %K (14, 3, 3)68.46
    Neutral
  • MACD Level (12, 26)0.79
    Buy

Peers & Related Assets

ALKSAlkermes plc
$45.4-0.2%
ANIPANI Pharmaceuticals, Inc.
$70.7+0.7%
PCRXPacira BioSciences, Inc.
$25.88+0.0%
COLLCollegium Pharmaceutical, Inc.
$23.36-0.0%
ANGOAngioDynamics, Inc.
$15.32+0.7%
RDYDr. Reddy's Laboratories Limited
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.